To further elucidate the changes in PD-1 levels on T cells in newly diagnosed AL patients after effective treatment, we assessed PD-1 expression on CD4+ and CD8+ T lymphocytes in 8 AML patients and 4 ALL patients who achieved complete remission after therapy. The gene discussed is CD8A; the disease is axial length measurement.